SCHEMBL7542402

SCHEMBL7542402

CCOc1ccc2c(c1)Oc1cc(O)ccc1C21OC(=O)c2c(OCC)cccc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.61
FTO Q9C0B1 9/20 0.50
HPGD P15428 3/20 0.50
MAPT P10636 3/20 0.50
MEN1 O00255 2/20 0.50
HTT P42858 2/20 0.50
KMT2A Q03164 2/20 0.50
CYP2C19 P33261 1/20 0.50
RECQL P46063 1/20 0.50
BLM P54132 1/20 0.50
SMAD3 P84022 1/20 0.50
PRMT1 Q99873 1/20 0.50
ACE2 Q9BYF1 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
ALDH1A1 P00352 3/20 0.48
ALOX12 P18054 2/20 0.48
HSD17B10 Q99714 2/20 0.48
CYP2C9 P11712 1/20 0.48
ALOX15 P16050 1/20 0.48
BRCA1 P38398 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7864064 0.95 FTO (0.55) CYP3A4FTOHPGDMAPTMEN1
SCHEMBL5176015 0.85 FTO (0.51) CYP3A4FTOHPGDMAPTMEN1
SCHEMBL3164943 0.84 CYP3A4 (0.87) CYP3A4FTOHPGDMAPTMEN1
SCHEMBL11666220 0.82 FTO (0.59) CYP3A4FTOHPGDMAPTMEN1
Naphthalene SCHEMBL3166641 0.81 CYP3A4 (0.81) CYP3A4FTOHPGDMAPTMEN1
SCHEMBL2314510 0.79 FTO (0.60) CYP3A4FTOHPGDMAPTMEN1
SCHEMBL385190 0.78 HPGD (0.53) CYP3A4FTOHPGDMAPTMEN1
SCHEMBL393726 0.78 FTO (0.47) CYP3A4FTOHPGDMAPTMEN1
SCHEMBL6685820 0.78 FTO (0.53) CYP3A4FTOHPGDMAPTMEN1
SCHEMBL5181388 0.77 FTO (0.47) CYP3A4FTOHPGDMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420131-B1 MONITORING PREFRENTIAL ENZYMATIC ACTIVITY; OBTAIN SAMPLE OF ENZYMATIC POLYPEPTIDE, INCUBATE WITH MODULATOR, EVALUATE THE MODULATOR ABILITY TO INHIBIT ENZYMATIC POLYPEPTIDE GENTEST CORPORATION 2002-07-16 US disclosed
EP-1210342-A1 THE USE OF FLUORESCEIN ARYL ETHERS IN HIGH THROUGHPUT CYTOCHROME P450 INHIBITION ASSAYS GENTEST CORPORATION (US) 2002-06-05 EP disclosed
WO-2001014361-A1 THE USE OF FLUORESCEIN ARYL ETHERS IN HIGH THROUGHPUT CYTOCHROME P450 INHIBITION ASSAYS GENTEST CORPORATION (US) 2001-03-01 WO disclosed